Patent details

Basic Information

Publication number:

EP2497772

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP121531313

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Compound for inhibiting mitotic progression

French Title of Invention:

Composé pour inhiber la progression mitotique

German Title of Invention:

Verbindung zur Hemmung der Mitoseprogression

SPC Number:

Dates

Filing date:

14/11/2007

Grant date:

29/10/2014

EP Publication Date:

29/10/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/09/2012

EP B1 Publication Date:

29/10/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

14/11/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/11/2007

 

 

Name:

Millennium Pharmaceuticals Inc.

Address:

40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

07/01/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Claiborne Christopher F.

Address:

United States (US)

2

Name:

Sells Todd B.

Address:

United States (US)

3

Name:

Stroud Stephen G.

Address:

United States (US)

Priority

Priority Number:

859340 P

Priority Date:

16/11/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 487/04;

Annual Fees

Annual Fee Due Date:

01/12/2025

Annual Fee Number:

19

Annual Fee Amount:

281 Euro

Expected Payer:

Last Annual Fee Payment Date:

22/10/2024

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages